InnoCare Pharma Ltd
SSE:688428

Watchlist Manager
InnoCare Pharma Ltd Logo
InnoCare Pharma Ltd
SSE:688428
Watchlist
Price: 13.34 CNY -6.78% Market Closed
Market Cap: 11.3B CNY
Have any thoughts about
InnoCare Pharma Ltd?
Write Note
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

10.3B
-1%
Assets
Dec 31, 2022 10.3B
Sep 30, 2022 10.4B
Jun 30, 2022 7.7B
2.7B
+1%
Liabilities
Dec 31, 2022 2.7B
Sep 30, 2022 2.7B
Jun 30, 2022 2.2B
7.6B
-2%
Equity
Dec 31, 2022 7.6B
Sep 30, 2022 7.7B
Jun 30, 2022 5.5B

Balance Sheet Decomposition
InnoCare Pharma Ltd

10.3B
Assets
2.7B
Liabilities
10.3B
Assets
2.7B
Liabilities
Current Assets 9.3B
Cash & Short-Term Investments 9.1B
Receivables 144.6m
Other Current Assets 101.4m
Non-Current Assets 1B
Long-Term Investments 11.7m
PP&E 696.5m
Intangibles 276.3m
Other Non-Current Assets 44.6m
Current Liabilities 2.1B
Accounts Payable 118.6m
Accrued Liabilities 57m
Other Current Liabilities 1.9B
Non-Current Liabilities 664m
Long-Term Debt 35.4m
Other Non-Current Liabilities 628.6m

Balance Sheet
InnoCare Pharma Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2020 Dec-2021 Dec-2022
Assets
Cash & Cash Equivalents
3 996
5 970
8 740
Cash
2 285
3 237
4 180
Cash Equivalents
1 711
2 732
4 560
Short-Term Investments
0
317
313
Total Receivables
52
66
145
Accounts Receivables
0
45
128
Other Receivables
52
21
17
Inventory
2
10
65
Other Current Assets
39
54
36
Total Current Assets
4 089
6 417
9 300
PP&E Net
330
546
696
PP&E Gross
330
546
696
Accumulated Depreciation
58
74
104
Intangible Assets
112
107
273
Goodwill
3
3
3
Long-Term Investments
1
326
12
Other Long-Term Assets
6
15
45
Other Assets
3
3
3
Total Assets
4 541
N/A
7 415
+63%
10 329
+39%
Liabilities
Accounts Payable
17
85
119
Accrued Liabilities
26
42
68
Short-Term Debt
0
0
1 197
Current Portion of Long-Term Debt
7
20
20
Other Current Liabilities
47
170
664
Total Current Liabilities
97
317
2 068
Long-Term Debt
1 167
1 286
35
Deferred Income Tax
6
0
0
Minority Interest
56
54
47
Other Liabilities
110
154
581
Total Liabilities
1 437
N/A
1 810
+26%
2 732
+51%
Equity
Common Stock
0
0
0
Retained Earnings
3 497
3 562
4 448
Additional Paid In Capital
6 977
9 632
12 082
Other Equity
376
466
36
Total Equity
3 104
N/A
5 605
+81%
7 597
+36%
Total Liabilities & Equity
4 541
N/A
7 415
+63%
10 329
+39%
Shares Outstanding
Common Shares Outstanding
1 764
1 764
1 764

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 198,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.